
Dual pathways.One provider-guided protocol.
Tirzepatide activates GLP-1 and GIP receptors — supporting appetite regulation through a broader metabolic signal when your Nexa Rx clinician determines it is appropriate.
Itemized quote before enrollment
A weekly dual-action GLP-1 + GIP injection for appetite regulation support when clinically appropriate.


Licensed U.S. providers, qualified pharmacy fulfillment, and clear pricing before you enroll — with flexibility to change or cancel per your program terms.
Final price depends on prescribed therapy, dosage, pharmacy, shipping, and state. All charges and recurring terms are shown before enrollment.
See if I qualify
Tirzepatide activates GLP-1 and GIP receptors — supporting appetite regulation through a broader metabolic signal when your Nexa Rx clinician determines it is appropriate.
Tirzepatide works on GLP-1 and GIP pathways — designed for patients who may benefit from stronger appetite and metabolic signaling.
Dosing starts low and increases gradually under licensed provider review — giving your body time to adapt safely.
Your care team adjusts the protocol based on how you respond, with secure messaging and refill review included in active care.
Nexa Rx · Personalized Tirzepatide · GLP-1 + GIP
Tirzepatide activates both GLP-1 and GIP receptors for stronger appetite regulation and a broader metabolic response when medically appropriate.
At Nexa Rx, your dosing protocol is reviewed and prescribed by a licensed U.S. provider, then adjusted as you progress — with clear pricing before enrollment.
No guesswork. Here's how the first months typically look for patients in the program. Individual experiences vary.

You start on a low dose — intentionally. Your treatment is introduced gradually so your body can adapt. Some patients notice appetite changes early; others take a few more weeks. Both are normal. Your clinician is available throughout.

As titration continues, your clinician monitors how you respond. Appetite signals and dosing may be adjusted based on your individual course — experiences vary, and treatment is not guaranteed to produce a specific outcome.

Your clinician fine-tunes your plan with real precision based on your response. The focus shifts from adjustment to consistency, and maintainable progress becomes the rhythm.

You start on a low dose — intentionally. Your treatment is introduced gradually so your body can adapt. Some patients notice appetite changes early; others take a few more weeks. Both are normal. Your clinician is available throughout.

As titration continues, your clinician monitors how you respond. Appetite signals and dosing may be adjusted based on your individual course — experiences vary, and treatment is not guaranteed to produce a specific outcome.

Your clinician fine-tunes your plan with real precision based on your response. The focus shifts from adjustment to consistency, and maintainable progress becomes the rhythm.
Before you begin
Clinical review, pricing, and delivery — the questions patients ask most before starting GLP-1 + GIP (Tirzepatide).
Tirzepatide is a dual GLP-1/GIP receptor agonist that may be prescribed for chronic weight management when medically appropriate. Nexa Rx connects you with licensed clinicians for evaluation and ongoing support.
Tirzepatide activates GLP-1 and GIP receptors. Semaglutide focuses on the GLP-1 pathway. Your clinician recommends therapy based on your history, goals, and clinical fit.
Eligibility is determined by a licensed provider after reviewing your medical history and symptoms. Treatment is not guaranteed and varies by state.
Complete secure intake, verify identity when required, and receive a licensed provider review — typically within 24 hours. If approved, pharmacy fulfillment and discreet delivery follow.
Side effects vary. Nausea, digestive changes, or appetite shifts may occur during titration. Your clinician monitors your response and adjusts dosing when needed.
Compounded tirzepatide is not an FDA-approved finished branded product. Your clinician may prescribe FDA-approved brands or compounded formulations where legally available — confirmed before you enroll.
Care blueprint
The Nexa Rx difference
Provider-guided Semaglutide & Tirzepatide — designed with clinical clarity, not checkout chaos.
From compounding partners to doorstep delivery — pharmaceutical-grade quality with clear, clinical oversight.
LegitScript certification — pending review · not yet verified
Semaglutide or Tirzepatide — protocols tailored to your goals, history, and how your body responds.
Weekly protocols guided by licensed clinicians for appetite regulation support — not guaranteed outcomes.

Your portal, care team, and treatment plan — organized in one place whenever you need them.

Clear pricing before enrollment. Discreet delivery when prescribed.
Check EligibilityExplore GLP-1 semaglutide therapy →
GLP-1 therapies require medical evaluation and a valid prescription. Compounded semaglutide and tirzepatide are not FDA-approved as finished branded products when dispensed in compounded form.
Broad availability across the U.S. with state-specific prescribing and pharmacy rules.